Alkermes Plc (ALKS)

56.55
NASDAQ : Health Technology
Prev Close 56.55
Day Low/High 0.00 / 0.00
52 Wk Low/High 46.42 / 71.22
Avg Volume 997.10K
Exchange NASDAQ
Shares Outstanding 156.14M
Market Cap 10.50B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of January 22 Deadline In Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of January 22 Deadline In Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, reminds investors that a class action lawsuit is pending against Alkermes plc (NASDAQ: ALKS) ("Alkermes" or...

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) of the January 22, 2018 deadline to seek the role of lead plaintiff in a...

Alkermes Is Getting Ready for a Rally

Alkermes Is Getting Ready for a Rally

ALKS's choppy trading period may be coming to a close.

Alkermes: Cramer's Top Takeaways

Alkermes: Cramer's Top Takeaways

Richard Pops, chairman and CEO of Alkermes, tells Jim Cramer about the company's 2018 outlook for drug development.

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

From global growth and bonds to index funds, Jim Cramer explains why stocks keep going up, giving the Dow and Nasdaq their best start to the new year since 2006.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Alkermes Plc Of Class Action Lawsuit And Upcoming Deadline - ALKS

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Alkermes Plc Of Class Action Lawsuit And Upcoming Deadline - ALKS

Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) and certain of its officers.

The Klein Law Firm Reminds Investors Of A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Reminds Investors Of A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Alkermes plc (NASDAQ:ALKS) who purchased shares between February 24, 2015 and November 3, 2017.

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes plc...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alkermes plc ("Alkermes") (NASDAQ: ALKS) between February 24,...

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Alkermes plc (NASDAQ: ALKS) who purchased shares between February 24, 2015 and November 3, 2017.

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes plc...

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alkermes plc ("Alkermes") (NASDAQ:ALKS) between February 24,...

Jobs Report Just Right for Stocks: Cramer's 'Mad Money' Recap (Friday 12/8/17)

Jobs Report Just Right for Stocks: Cramer's 'Mad Money' Recap (Friday 12/8/17)

Jim Cramer sees support in the jobs report, and has the game plan ready for next week, including the Fed and earnings.

Nucor, Alkermes, T-Mobile, Axon Enterprise: 'Mad Money' Lightning Round

Nucor, Alkermes, T-Mobile, Axon Enterprise: 'Mad Money' Lightning Round

Jim Cramer is bullish on Nucor, Axon Enterprise, Alkermes, T-Mobile US, Verizon.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Alkermes Plc

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Alkermes Plc

The Klein Law Firm announces the commencement of an investigation of Alkermes plc (NASDAQ:ALKS) concerning possible violations of federal securities laws.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Alkermes Plc

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Alkermes Plc

The Klein Law Firm announces the commencement of an investigation of Alkermes plc (NASDAQ: ALKS) concerning possible violations of federal securities laws.

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) violated federal securities laws.

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Alkermes plc ("Alkermes" or the "Company") (NASDAQ: ALKS) violated federal securities laws.

Scott+Scott, Attorneys At Law, LLP Alerts Investors To The Filing Of A Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys At Law, LLP Alerts Investors To The Filing Of A Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Alkermes plc (NASDAQ:ALKS)...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

Levi & Korsinsky announces it has commenced an investigation of Alkermes plc (NASDAQ:ALKS) concerning possible violations of federal securities laws.

Alkermes Jumps on License Deal With Biogen -- Biotech Movers

Alkermes Jumps on License Deal With Biogen -- Biotech Movers

Alkermes and Biogen have inked a pact to develop and commercialize ALKS 8700, which is in Phase 3 development for treating relapsing forms of multiple sclerosis.

Http://www.alkermes.com/

Http://www.alkermes.com/

Biogen (Nasdaq:BIIB) and Alkermes plc (Nasdaq:ALKS) today announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel, oral, monomethyl...

TheStreet Quant Rating: C- (Hold)